EMAGIN CORPORATION (EMAN) Fundamental Analysis & Valuation
NYSEARCA:EMAN • US29076N2062
Current stock price
2.07 USD
+0.06 (+2.99%)
At close:
2.07 USD
0 (0%)
After Hours:
This EMAN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. EMAN Profitability Analysis
1.1 Basic Checks
- EMAN had negative earnings in the past year.
- In the past year EMAN has reported a negative cash flow from operations.
1.2 Ratios
- EMAN has a Return On Assets of -18.20%. This is amonst the worse of the industry: EMAN underperforms 83.02% of its industry peers.
- EMAN has a Return On Equity of -114.25%. This is amonst the worse of the industry: EMAN underperforms 88.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.2% | ||
| ROE | -114.25% | ||
| ROIC | N/A |
ROA(3y)-11.89%
ROA(5y)-17.55%
ROE(3y)-34.55%
ROE(5y)-36.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a Gross Margin value of 26.24%, EMAN is not doing good in the industry: 80.19% of the companies in the same industry are doing better.
- In the last couple of years the Gross Margin of EMAN has grown nicely.
- The Profit Margin and Operating Margin are not available for EMAN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 26.24% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.34%
GM growth 5Y7.77%
2. EMAN Health Analysis
2.1 Basic Checks
- EMAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
- EMAN has more shares outstanding than it did 1 year ago.
- EMAN has a better debt/assets ratio than last year.
2.2 Solvency
- EMAN has an Altman-Z score of -3.59. This is a bad value and indicates that EMAN is not financially healthy and even has some risk of bankruptcy.
- EMAN's Altman-Z score of -3.59 is on the low side compared to the rest of the industry. EMAN is outperformed by 81.13% of its industry peers.
- A Debt/Equity ratio of 1.59 is on the high side and indicates that EMAN has dependencies on debt financing.
- EMAN's Debt to Equity ratio of 1.59 is on the low side compared to the rest of the industry. EMAN is outperformed by 87.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.59 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.59 |
ROIC/WACCN/A
WACC12.71%
2.3 Liquidity
- EMAN has a Current Ratio of 2.06. This indicates that EMAN is financially healthy and has no problem in meeting its short term obligations.
- EMAN has a Current ratio of 2.06. This is in the lower half of the industry: EMAN underperforms 75.47% of its industry peers.
- EMAN has a Quick Ratio of 1.16. This is a normal value and indicates that EMAN is financially healthy and should not expect problems in meeting its short term obligations.
- EMAN has a worse Quick ratio (1.16) than 81.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.16 |
3. EMAN Growth Analysis
3.1 Past
- EMAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -650.00%.
- Looking at the last year, EMAN shows a small growth in Revenue. The Revenue has grown by 0.19% in the last year.
- The Revenue has been growing slightly by 6.74% on average over the past years.
EPS 1Y (TTM)-650%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-550%
Revenue 1Y (TTM)0.19%
Revenue growth 3Y4.54%
Revenue growth 5Y6.74%
Sales Q2Q%-30.79%
3.2 Future
- EMAN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -177.41% yearly.
- The Revenue is expected to grow by 2.91% on average over the next years.
EPS Next Y-1648.97%
EPS Next 2Y-177.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-25.5%
Revenue Next 2Y2.91%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. EMAN Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for EMAN. In the last year negative earnings were reported.
- Also next year EMAN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as EMAN's earnings are expected to decrease with -177.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-177.41%
EPS Next 3YN/A
5. EMAN Dividend Analysis
5.1 Amount
- EMAN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EMAN Fundamentals: All Metrics, Ratios and Statistics
2.07
+0.06 (+2.99%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-10 2023-08-10/bmo
Earnings (Next)11-08 2023-11-08/bmo
Inst Owners0.75%
Inst Owner Change0%
Ins Owners0.12%
Ins Owner Change0%
Market Cap172.20M
Revenue(TTM)27.56M
Net Income(TTM)-13.32M
Analysts82.5
Price Target3.06 (47.83%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-210.46%
Min EPS beat(2)-324.84%
Max EPS beat(2)-96.08%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-22.35%
Min Revenue beat(2)-30.23%
Max Revenue beat(2)-14.46%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-60%
EPS NY rev (1m)0%
EPS NY rev (3m)-138.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-33.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.84%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 6.25 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 14.77 | ||
| P/tB | 14.81 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.33
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.2% | ||
| ROE | -114.25% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 26.24% | ||
| FCFM | N/A |
ROA(3y)-11.89%
ROA(5y)-17.55%
ROE(3y)-34.55%
ROE(5y)-36.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.34%
GM growth 5Y7.77%
F-Score2
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.59 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 583.49% | ||
| Cap/Sales | 56.54% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.16 | ||
| Altman-Z | -3.59 |
F-Score2
WACC12.71%
ROIC/WACCN/A
Cap/Depr(3y)406.79%
Cap/Depr(5y)278.01%
Cap/Sales(3y)39.01%
Cap/Sales(5y)25.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-650%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-550%
EPS Next Y-1648.97%
EPS Next 2Y-177.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.19%
Revenue growth 3Y4.54%
Revenue growth 5Y6.74%
Sales Q2Q%-30.79%
Revenue Next Year-25.5%
Revenue Next 2Y2.91%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-69.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year84.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-196.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.32%
OCF growth 3YN/A
OCF growth 5YN/A
EMAGIN CORPORATION / EMAN Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for EMAGIN CORPORATION?
ChartMill assigns a fundamental rating of 1 / 10 to EMAN.
What is the valuation status for EMAN stock?
ChartMill assigns a valuation rating of 0 / 10 to EMAGIN CORPORATION (EMAN). This can be considered as Overvalued.
Can you provide the profitability details for EMAGIN CORPORATION?
EMAGIN CORPORATION (EMAN) has a profitability rating of 1 / 10.
Can you provide the financial health for EMAN stock?
The financial health rating of EMAGIN CORPORATION (EMAN) is 2 / 10.